Stop the clot! Just six extra minutes to save cancer patients

December 2, 2015 by Sarah Keenihan, The Lead
3d rendered close up of a blood clot.

Blood clots and infections are the leading killers of patients being treated for cancer. Rebecca Sharp, a nursing lecturer from University of South Australia, has devised a simple method that will reduce the development of clots and save patients' lives.

"Clots form around the tubes that deliver drugs into patients' veins, and can then break off to block to the lungs or cause other dangers to the patient's health," Rebecca said.

"My studies show that the simple act of finding a vein of appropriate size before inserting the delivery device can make a difference."

Rebecca used ultrasound to study vein size in patients receiving hospital treatment for cancer. She found that to reduce the risk of clotting, the intravenous delivery device should occupy less than 45% of the selected vein width.

"Taking up more of the vein increases the risk of a blood clot by more than 10 times," she said.

What's more, to get this 10 fold benefit takes just an extra six minutes to find a vein of the right size by ultrasound.

Rebecca's research focused on a delivery device known as a PICC – Peripherally Inserted Central Catheter. PICCs are inserted through a vein in the arm, and guided internally so that the tip rests inside a large blood vessel just near the lungs.

"We call the PICC a 'one stop shop' for cancer therapies – once it's in the right place, you can administer chemotherapy and other systemic treatments through that one vein," explained Rebecca.

"It also provides a single access point to collect blood for the many tests that cancer patients often require."

When properly in place, the PICC reduces the level of trauma experienced by the cancer patient. However, when a blood clot forms at the insertion site, it creates not only an elevated immediate risk of death but also a much more complex medical journey.

"Often the PICC will be removed, and then the patient must undergoes months of extra treatment to remove the clot and prevent further clotting taking place," Rebecca said.

"It also creates a lot of initial extra pain and swelling."

These results have been published in the International Journal of Nursing Studies.

Related research showed that there is considerable variation in vein size across patients – despite medical textbooks suggesting otherwise – and that an infusion nurse can reliability measure vein diameter in the PICC clinic.

"All should be assessed to find the right vein before chemotherapy commences," said Rebecca.

Rebecca's findings have already made their way into the broader hospital setting, and are now part of the training provided to both nurses and doctors in main teaching hospitals in Adelaide.

Explore further: Peripherally inserted central catheters can cause blood clots in lower limbs

More information: Rebecca Sharp et al. The catheter to vein ratio and rates of symptomatic venous thromboembolism in patients with a peripherally inserted central catheter (PICC): A prospective cohort study, International Journal of Nursing Studies (2015). DOI: 10.1016/j.ijnurstu.2014.12.002

Rebecca Sharp et al. Measurement of Vein Diameter for Peripherally Inserted Central Catheter (PICC) Insertion, Journal of Infusion Nursing (2015). DOI: 10.1097/NAN.0000000000000125

Rebecca Sharp et al. Vein Measurement by Peripherally Inserted Central Catheter Nurses Using Ultrasound: A Reliability Study, Journal of the Association for Vascular Access (2013). DOI: 10.1016/j.java.2013.08.001

Related Stories

Peripherally inserted central catheters can cause blood clots in lower limbs

August 17, 2015
Peripherally inserted central catheters (PICCs), a type of IV typically inserted in a vein in the arm, are frequently used by healthcare professionals to obtain long-term central venous access in hospitalized patients. While ...

Commonly used catheters double risk of blood clots in ICU and cancer patients

May 20, 2013
Touted for safety, ease and patient convenience, peripherally inserted central catheters have become many clinicians' go-to for IV delivery of antibiotics, nutrition, chemotherapy, and other medications.

Serious risks from common IV devices mean doctors should choose carefully, experts say

March 20, 2015
Every day, patients around the country get IV devices placed in their arms, to make it easier to receive medicines or have blood drawn over the course of days or weeks. But these PICC lines, as they're called, also raise ...

Subclavian vein catheterization beats jugular, femoral placement

September 25, 2015
(HealthDay)—For patients in intensive care units who need a catheter, placement in the subclavian vein appears to lower the risk of bloodstream infection and deep-vein thrombosis, compared to jugular or femoral placement, ...

Is your doctor choosing the right IV?

October 26, 2015
When we doctors sit down with patients in the hospital, discussions regarding diagnosis and prognosis are routine. For patients who need treatments such as antibiotics or chemotherapy beyond the hospital, our conversations ...

Close-to-the-heart catheters safer for hospitalized children

March 18, 2013
Location, location, location. A new Johns Hopkins Children's Center study shows the real-estate mantra also holds true when it comes to choosing correct catheter placement in children.

Recommended for you

Research shows possible new target for immunotherapy for solid tumors

April 24, 2018
Research from the University of Cincinnati (UC) reveals a potential new target to help T cells (white blood cells) infiltrate certain solid tumors.

Changes in breast tissue increase cancer risk for older women

April 24, 2018
Researchers in Norway, Switzerland, and the United States have identified age-related differences in breast tissue that contribute to older women's increased risk of developing breast cancer. The findings, published April ...

Targeting molecules called miR-200s and ADAR2 could prevent tumor metastasis in patients with colorectal cancer

April 24, 2018
Colorectal cancer is the third most common cancer worldwide and the third-leading cause of cancer-related deaths. The main cause of death in patients with colorectal cancer is liver metastasis, with nearly 70% of patients ...

Removing the enablers: Reducing number of tumor-supporting cells to fight neuroblastoma

April 24, 2018
Investigators at the Children's Center for Cancer and Blood Diseases at Children's Hospital Los Angeles provide preclinical evidence that the presence of tumor-associated macrophages—a type of immune cell—can negatively ...

Technology used to map Mars now measuring effect of treatment on tumours

April 24, 2018
A machine learning approach for assessing images of the craters and dunes of Mars, which was developed at The University of Manchester, has now been adapted to help scientists measure the effects of treatments on tumours.

New test could tell doctors whether patients will respond to chemotherapy

April 24, 2018
Less than half the patients diagnosed with cancer respond favorably to chemotherapy, but a new method for testing how patients will respond to various drugs could pave the way for more personalized treatment.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.